<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Original Article: Assessing PRISM Context Domains and RE-AIM Outcomes: Data From Use of the Iterative PRISM Webtool

Russell Glasgow, PhD, is first author of this Implementation Science Communications Publication.

minute read

by Brittany Manansala | August 27, 2026
Technical research icons surrounding a person holding a phone.

“Assessing PRISM Context Domains and RE-AIM Outcomes: Data From Use of the Iterative PRISM Webtool.”

June 2026

Implementation Science Communications

Russell Glasgow, PhD, Research Professor of Family Medicine at CU Anschutz, is first author of an Implementation Science Communications publication titled, “Assessing PRISM Context Domains and RE-AIM Outcomes: Data From Use of the Iterative PRISM Webtool.”

From the article:

“Use of an implementation science (IS) theory, model, or framework (TMF) is one of the hallmarks of a well-executed IS study. Although TMFs are frequently used in IS studies, the TMFs themselves are seldom evaluated. Understanding the relationships between the constructs within an IS TMF and their effect on the implementation and effectiveness outcomes can help to refine the TMF, advance IS and assist implementers.

We evaluated several hypotheses pertinent to the context domains and Reach, Effectiveness Adoption, Implementation, and Maintenance (RE-AIM) outcomes from the Practical, Robust Implementation and Sustainability Framework (PRISM). Data for these evaluations emerged from the use of the Iterative PRISM (iPRISM) webtool, which includes 21 assessment questions that operationalize PRISM context and outcomes constructs. We tested 11 ‘a priori’ hypotheses including relationships within and between different framework constructs and considered whether some of the webtool’s assessment questions could be refined or changed to make the assessment more pragmatic and helpful.”

Other DFM contributors include (individuals listed alphabetically): Carlos Rodriguez, PhD; Katy Trinkley, PharmD, PhD, and Jun Ying, PhD.

Read more about this article.

russell-e-glasgow-phd carlos-rodriguez-thumbnails.tmb-image350

Trinkley Jun-Ying-299x357

Comments